A judge has signed off on a $38 million settlement in a shareholder class action against Mayne Pharma but has slashed a 27.9 per cent commission for the funder that backed the case. Victorian Supreme Court Justice Andrew Watson approved the settlement on 19 December, including $6 million in legal costs and a 25.7 per…
Accounting disciplinary body Chartered Accountants ANZ has dropped its investigation into former PwC tax partner Wayne Plummer, who was linked to the firm’s tax leaks scandal in 2023.
Developer Freecity has won court approval for its plans for a 19-level, $230 million student accommodation development near Macquarie University, after its plans were initially knocked back by the local council.
Allens has brokered a deal between Australian renewable company ZEN Energy and Taiwanese company HDRE to create a battery system that will increase national solar storage by 33 per cent.
Animal health company Virbac has lost its interlocutory bid to block a generic version of its animal drug Cydectin Platinum by rival Abbey Laboratories.
Shareholders in collapsed financial services firm Babcock & Brown have lost their bid to stay costs orders after losing a ten-year-old dispute.
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Two Queensland solicitors have scored partial wins in their decades-long disputes with the tax office because of the Administrative Appeals Tribunal’s “wholesale failure” to give proper reasons.
An intellectual property firm has lost its legal challenge to Apple’s bid to patent its method of authentication on electronic devices, including smartphones.